This announcement is a separate document:
中智藥業：與二零二二年年報有關之補充公告
ZHONGZHIPHARM: SUPPLEMENTARY ANNOUNCEMENTIN RELATION TO THE 2022 ANNUAL REPORT
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.